Somerville, MA, United States of America

Kimberly Ann Marquette

This inventor holds 18 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Pfizer Corporation, Wyeth, Beth Israel Deaconess Medical Center, Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimberly Ann Marquette. Retrieved from https://idiyas.com/inventor/kimberly-ann-marquette

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 15)

% Patents Active = 44.4

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 8 (Patent Applications = 17)

Average Co-Inventor Count = 7.6

ph-index = 7

Forward Citations = 230(Granted Patents)

Company Filing History:

Beth Israel Deaconess Medical Center, Inc.

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653901 - ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES (2026-06-16),

2. 12636377 - ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES (2026-05-26),

3. 12371507 - CDCP1 antibodies and antibody drug conjugates (2025-07-29),

4. 11833216 - Anti-EDB antibodies and antibody-drug conjugates (2023-12-05),

5. 11147852 - Engineered antibody constant regions for site-specific conjugation and methods and uses therefor (2021-10-19),

6. 10689458 - Site specific HER2 antibody drug conjugates (2020-06-23),

7. 10392438 - Bispecific antibodies (2019-08-27),

8. 10189896 - Antibody to GDF8 and uses thereof (2019-01-29),

9. 9902771 - Anti-5T4 antibodies and uses thereof (2018-02-27),

10. 9850301 - Antibody to GDF8 and uses thereof (2017-12-26),

11. 9409981 - Antibody to GDF8 and uses thereof (2016-08-09),

12. 8759495 - Anti-5T4 antibodies and uses thereof (2014-06-24),

13. 8586049 - Antibody-drug conjugates (2013-11-19),

14. 8415459 - Antibody to GDF8 and uses thereof (2013-04-09),

15. 8309094 - Antibody-drug conjugates (2012-11-13),

Title: The Innovative Contributions of Kimberly Ann Marquette

Introduction

Kimberly Ann Marquette is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies. With a total of 18 patents to her name, her work has had a substantial impact on medical research and treatment options.

Latest Patents

Among her latest patents are the CDCP1 antibodies and antibody drug conjugates. This patent provides materials and methods for CUB domain-containing protein 1 (CDCP1)-targeted therapy. Another notable invention is the anti-EDB antibodies and antibody-drug conjugates, which bind to the extra domain B splice variant of fibronectin 1 and outline methods for their preparation and use.

Career Highlights

Throughout her career, Kimberly has worked with leading companies in the pharmaceutical industry, including Pfizer Corporation and Wyeth. Her experience in these organizations has allowed her to develop innovative solutions that address critical health challenges.

Collaborations

Kimberly has collaborated with esteemed colleagues such as Lioudmila Tchistiakova and Geertruida Machteld Veldman. These partnerships have further enhanced her research and development efforts.

Conclusion

Kimberly Ann Marquette's contributions to biotechnology and her impressive portfolio of patents underscore her role as a leading inventor in her field. Her work continues to influence advancements in targeted therapies and medical treatments.

Profile summary based on public USPTO records.